Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Epidemiologic evaluation of antimicrobial resistance in community-acquired enterococci.

Literature DB >> 9508325

Epidemiologic evaluation of antimicrobial resistance in community-acquired enterococci.

J Silverman¹, L A Thal, M B Perri, G Bostic, M J Zervos.

Abstract

Fecal samples from 200 consecutive patients admitted to a community hospital yielded 107 enterococci. High-level gentamicin resistance occurred in 10 (14%) of the Enterococcus faecalis isolates. Ampicillin resistance occurred in two (3%) of the E. faecalis isolates and six (23%) of the Enterococcus faecium isolates. There were no vancomycin-resistant enterococci. Risk factors for enterococci with high-level aminoglycoside (gentamicin) or ampicillin resistance included prior hospitalization and previous antibiotic use.

Entities: Chemical Species

Mesh：

Substances：

Year: 1998 PMID： 9508325 PMCID： PMC104638 DOI： 10.1128/JCM.36.3.830-832.1998

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

26 in total

1. High-level resistance to gentamicin in Streptococcus faecalis: risk factors and evidence for exogenous acquisition of infection.

Authors: M J Zervos; S Dembinski; T Mikesell; D R Schaberg
Journal: J Infect Dis Date: 1986-06 Impact factor: 5.226

2. Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci.

Authors: P Van der Auwera; N Pensart; V Korten; B E Murray; R Leclercq
Journal: J Infect Dis Date: 1996-05 Impact factor: 5.226

3. High-level resistance to aminoglycosides: comparison of community and nosocomial fecal isolates of enterococci.

Authors: T M Coque; R C Arduino; B E Murray
Journal: Clin Infect Dis Date: 1995-04 Impact factor: 9.079

4. Characterization of antimicrobial resistance in enterococci of animal origin.

Authors: L A Thal; J W Chow; R Mahayni; H Bonilla; M B Perri; S A Donabedian; J Silverman; S Taber; M J Zervos
Journal: Antimicrob Agents Chemother Date: 1995-09 Impact factor: 5.191

5. vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry.

Authors: I Klare; H Heier; H Claus; R Reissbrodt; W Witte
Journal: FEMS Microbiol Lett Date: 1995-01-15 Impact factor: 2.742

6. Evidence for an animal origin of vancomycin-resistant enterococci.

Authors: J Bates; Z Jordens; J B Selkon
Journal: Lancet Date: 1993-08-21 Impact factor: 79.321

7. Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster.

Authors: F M Aarestrup; P Ahrens; M Madsen; L V Pallesen; R L Poulsen; H Westh
Journal: Antimicrob Agents Chemother Date: 1996-08 Impact factor: 5.191

8. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance.

Authors: J M Boyce; S M Opal; J W Chow; M J Zervos; G Potter-Bynoe; C B Sherman; R L Romulo; S Fortna; A A Medeiros
Journal: J Clin Microbiol Date: 1994-05 Impact factor: 5.948

9. Enterococci. Biologic and epidemiologic characteristics and in vitro susceptibility.

Authors: D Kaye
Journal: Arch Intern Med Date: 1982-10-25

10. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium.

Authors: J Z Jordens; J Bates; D T Griffiths
Journal: J Antimicrob Chemother Date: 1994-10 Impact factor: 5.790

17 in total

1. Molecular epidemiology of vancomycin-resistant Enterococcus faecium in a large urban hospital over a 5-year period.

Authors: W E Bischoff; T M Reynolds; G O Hall; R P Wenzel; M B Edmond
Journal: J Clin Microbiol Date: 1999-12 Impact factor: 5.948

2. Prevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and nonhospitalized controls in a cattle-rearing area of France.

Authors: K Gambarotto; M C Ploy; P Turlure; C Grélaud; C Martin; D Bordessoule; F Denis
Journal: J Clin Microbiol Date: 2000-02 Impact factor: 5.948

3. Vancomycin-resistant enterococci in Canada revisited.

Authors: B L Johnston; J M Conly
Journal: Can J Infect Dis Date: 2000-05

4. Use of colony morphology to distinguish different enterococcal strains and species in mixed culture from clinical specimens.

Authors: Shabnam Qamer; Jonathan A T Sandoe; Kevin G Kerr
Journal: J Clin Microbiol Date: 2003-06 Impact factor: 5.948

5. Molecular characterization of gentamicin-resistant Enterococci in the United States: evidence of spread from animals to humans through food.

Authors: S M Donabedian; L A Thal; E Hershberger; M B Perri; J W Chow; P Bartlett; R Jones; K Joyce; S Rossiter; K Gay; J Johnson; C Mackinson; E Debess; J Madden; F Angulo; M J Zervos
Journal: J Clin Microbiol Date: 2003-03 Impact factor: 5.948

6. Comparison of glycopeptide-resistant Enterococcus faecium isolates and glycopeptide resistance genes of human and animal origins.

Authors: P R Descheemaeker; S Chapelle; L A Devriese; P Butaye; P Vandamme; H Goossens
Journal: Antimicrob Agents Chemother Date: 1999-08 Impact factor: 5.191

7. Near absence of vancomycin-resistant enterococci but high carriage rates of quinolone-resistant ampicillin-resistant enterococci among hospitalized patients and nonhospitalized individuals in Sweden.

Authors: E Torell; O Cars; B Olsson-Liljequist; B M Hoffman; J Lindbäck; L G Burman
Journal: J Clin Microbiol Date: 1999-11 Impact factor: 5.948